AU6281100A - Novel diketopiperazines - Google Patents

Novel diketopiperazines

Info

Publication number
AU6281100A
AU6281100A AU62811/00A AU6281100A AU6281100A AU 6281100 A AU6281100 A AU 6281100A AU 62811/00 A AU62811/00 A AU 62811/00A AU 6281100 A AU6281100 A AU 6281100A AU 6281100 A AU6281100 A AU 6281100A
Authority
AU
Australia
Prior art keywords
diketopiperazines
novel
novel diketopiperazines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62811/00A
Inventor
Wolfram Bode
Robert Huber
Luis Moroder
Norbert Schaschke
Christian Sommerhoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV, Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of AU6281100A publication Critical patent/AU6281100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU62811/00A 1999-08-10 2000-08-08 Novel diketopiperazines Abandoned AU6281100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19937721A DE19937721A1 (en) 1999-08-10 1999-08-10 New diketopiperazines
DE19937721 1999-08-10
PCT/EP2000/007707 WO2001010845A1 (en) 1999-08-10 2000-08-08 Novel diketopiperazines

Publications (1)

Publication Number Publication Date
AU6281100A true AU6281100A (en) 2001-03-05

Family

ID=7917838

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62811/00A Abandoned AU6281100A (en) 1999-08-10 2000-08-08 Novel diketopiperazines

Country Status (3)

Country Link
AU (1) AU6281100A (en)
DE (1) DE19937721A1 (en)
WO (1) WO2001010845A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0112969A (en) 2000-08-04 2004-06-22 Dmi Biosciences Inc Method of using diketopiperazines and compositions containing them
DK1358182T3 (en) 2001-01-31 2004-12-20 Altana Pharma Ag Diazocin derivatives and their use as tryptase inhibitors
ES2287268T3 (en) 2001-02-21 2007-12-16 Nycomed Gmbh TRIPTASE INHIBITORS.
EP1368317B1 (en) 2001-02-21 2006-12-27 Altana Pharma AG Tryptase inhibitors
WO2002102771A1 (en) 2001-06-19 2002-12-27 Altana Pharma Ag Tryptase inhibitors
EP1571970B1 (en) 2002-10-02 2011-08-17 DMI Biosciences, Inc. Diagnosis and monitoring of diseases
US7732403B2 (en) 2003-05-15 2010-06-08 Dmi Biosciences, Inc. Treatment of T-cell mediated diseases
WO2008014613A1 (en) * 2006-08-04 2008-02-07 Manus Pharmaceuticals (Canada) Ltd. Multifunctional bioactive compounds
US8217047B2 (en) 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
CN104910025B (en) 2008-11-07 2019-07-16 麻省理工学院 Alkamine lipid and its purposes
CA2810844C (en) 2010-09-07 2017-03-21 Dmi Acquisition Corp. Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
KR20130127446A (en) * 2010-10-29 2013-11-22 론자 아게 (론자 엘티디.) Diketopiperazine forming dipeptidyl linker
WO2012135025A2 (en) 2011-03-28 2012-10-04 Massachusetts Institute Of Technology Conjugated lipomers and uses thereof
PL2766029T3 (en) 2011-10-10 2020-08-24 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
WO2013055749A1 (en) 2011-10-10 2013-04-18 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
KR102272498B1 (en) 2011-10-27 2021-07-06 메사추세츠 인스티튜트 오브 테크놀로지 Amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
JP6231484B2 (en) 2011-10-28 2017-11-15 アンピオ ファーマシューティカルズ，インコーポレイテッド Rhinitis treatment
CN105101965B (en) 2013-03-15 2021-03-09 安皮奥制药股份有限公司 Compositions for stem cell mobilization, homing, expansion and differentiation and methods of use thereof
RU2736513C2 (en) 2014-08-18 2020-11-17 Ампио Фармасьютикалз, Инк. Treating pathological conditions of joints
AU2016278970B2 (en) 2015-06-19 2020-10-29 Massachusetts Institute Of Technology Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
CN113072506B (en) * 2021-04-29 2022-05-27 陕西慧康生物科技有限责任公司 Synthetic method of cyclic dipeptide containing aspartic acid and glutamic acid
CN113214168B (en) * 2021-04-29 2022-09-27 陕西慧康生物科技有限责任公司 Method for synthesizing cyclic dipeptide containing glutamic acid and aspartic acid by solid-liquid combination
CN113292508B (en) * 2021-06-07 2022-09-27 陕西慧康生物科技有限责任公司 Synthetic method of cyclic dipeptide containing asparagine or glutamine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693338A (en) * 1994-09-29 1997-12-02 Emisphere Technologies, Inc. Diketopiperazine-based delivery systems
FR2717484A1 (en) * 1994-03-16 1995-09-22 Pf Medicament New pseudo-bis-peptide cpds.
JP2000500461A (en) * 1995-11-13 2000-01-18 スミスクライン・ビーチャム・コーポレイション Blood regulatory compounds

Also Published As

Publication number Publication date
DE19937721A1 (en) 2001-02-15
WO2001010845A1 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
AU1278701A (en) Novel compounds
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU2001271434A1 (en) Novel skateboard-bicycle combination
AU6281100A (en) Novel diketopiperazines
AU2408300A (en) Novel compounds
AU3670000A (en) Novel thiazolobenzimidazole derivatives
AU5429000A (en) Novel bicyclonucleoside derivatives
AU2804600A (en) Arylaminoalkylamides
AU2023701A (en) Sketcher
AU2699800A (en) Organoceramics
AU4568900A (en) Improved can
AU2359301A (en) Novel ss-defensins
AU4132200A (en) Novel compounds
AU2109700A (en) Novel compounds
AU1901801A (en) Glucofuranoses
AU6567400A (en) Substituted 2-imino-thiazolines
AU1915601A (en) Periotome
AU2582200A (en) Windturbine
AU2288900A (en) Novel compounds
AU2197301A (en) Microlamp
AU2985200A (en) Novel sialoadhesins
AU7784700A (en) Novel compounds
AU4156800A (en) Novel compounds
AU1385701A (en) Novel compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase